atenolol has been researched along with Chronic Kidney Diseases in 7 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Baseline estimated GFR (eGFR) and change in eGFR during follow-up were examined in relation to average on-treatment SBP in 8778 hypertensive patients with ECG left ventricular hypertrophy (LVH) randomly assigned to losartan- or atenolol-based treatment." | 5.22 | Impact of achieved systolic blood pressure on renal function in hypertensive patients. ( Devereux, RB; Kjeldsen, SE; Okin, PM, 2016) |
| "Atenolol treatment initiation was associated with lower 90-day risk of mortality than metoprolol tartrate (incidence, 0." | 1.40 | Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults. ( Devereaux, PJ; Fleet, JL; Garg, AX; Jain, AK; McArthur, E; Ozair, S; Roberts, MA; Weir, MA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Mitsuboshi, S | 1 |
| Niimura, T | 1 |
| Aizawa, F | 1 |
| Goda, M | 1 |
| Zamami, Y | 1 |
| Ishizawa, K | 1 |
| Duggal, V | 1 |
| Thomas, IC | 1 |
| Montez-Rath, ME | 1 |
| Chertow, GM | 1 |
| Kurella Tamura, M | 1 |
| Okin, PM | 1 |
| Kjeldsen, SE | 1 |
| Devereux, RB | 1 |
| Zoccali, C | 1 |
| Mallamaci, F | 1 |
| Fleet, JL | 1 |
| Weir, MA | 1 |
| McArthur, E | 1 |
| Ozair, S | 1 |
| Devereaux, PJ | 1 |
| Roberts, MA | 1 |
| Jain, AK | 1 |
| Garg, AX | 1 |
| Randhawa, SK | 1 |
| Elliott, WJ | 1 |
| Lely, AT | 1 |
| van der Kleij, FG | 1 |
| Kistemaker, TJ | 1 |
| Apperloo, AJ | 1 |
| de Jong, PE | 1 |
| de Zeeuw, D | 1 |
| Navis, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Triple-Blind, Parallel Study to Investigate the Effect of Losartan Versus Atenolol on the Reduction of Morbidity and Mortality in Hypertensive Patients With Left Ventricular Hypertrophy[NCT00338260] | Phase 3 | 496 participants (Actual) | Interventional | 1995-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for atenolol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Impact of achieved systolic blood pressure on renal function in hypertensive patients.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Electrocardiography; Female; Glomerular Fil | 2016 |
Impact of the preintervention rate of renal function decline on outcome of renoprotective intervention.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Creatinine; Disease Progression; Enalapril | 2008 |
5 other studies available for atenolol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Atenolol and mortality events in patients with chronic kidney disease: Analysis of data from the Japanese Adverse Drug Event Report database.
Topics: Adrenergic beta-Antagonists; Atenolol; Drug-Related Side Effects and Adverse Reactions; Female; Huma | 2022 |
National Estimates of CKD Prevalence and Potential Impact of Estimating Glomerular Filtration Rate Without Race.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anti-Bac | 2021 |
Cardiovascular protection by β-blockade in hypertensive haemodialysis patients: the Hypertension in Haemodialysis Patients Treated With Atenolol or Lisinopril (HDPAL) trial.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiotonic Agents; Humans; Hyperten | 2014 |
Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Atenolol; Coh | 2014 |
Therapy: atenolol versus metoprolol tartrate--conflicting outcomes data.
Topics: Adrenergic beta-1 Receptor Antagonists; Atenolol; Female; Humans; Kidney; Male; Metoprolol; Populati | 2014 |